Long only, growth, momentum

Implant Sciences: Sometimes Facts Lie

Sometimes facts lie. More specifically, they don't tell the whole truth. Implant Sciences' (IMSC.PK) third quarter and nine month results showed dramatic gains in revenues, 84 percent in Q3, 237 percent for the nine month period. On the face of it, exceptional.

However, the company also reported a net loss for the third quarter of $5.3 million compared to $3.9 the prior year, and a net loss of $21.8 million for the nine month period compared to a net loss of $10.3 million the prior nine months. On the face of it, depressing.

So what is it!? Does rapid top line growth indicate the company will shortly turn the corner to profitability? Or will bottom line hemorrhaging mean the company...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details